Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes

Thiago M. De Assuncao, Yan Sun, Nidhi Jalan-Sakrikar, Mary C. Drinane, Bing Q. Huang, Ying Li, Jaime I. Davila, Ruisi Wang, Steven P. O'Hara, Gwen A. Lomberk, Raul A. Urrutia, Yasuhiro H Ikeda, Robert C Huebert

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Cholangiocytes are the target of a heterogeneous group of liver diseases known as the cholangiopathies. An evolving understanding of the mechanisms driving biliary development provides the theoretical underpinnings for rational development of induced pluripotent stem cell (iPSC)-derived cholangiocytes (iDCs). Therefore, the aims of this study were to develop an approach to generate iDCs and to fully characterize the cells in vitro and in vivo. Human iPSC lines were generated by forced expression of the Yamanaka pluripotency factors. We then pursued a stepwise differentiation strategy toward iDCs, using precise temporal exposure to key biliary morphogens, and we characterized the cells, using a variety of morphologic, molecular, cell biologic, functional, and in vivo approaches. Morphology shows a stepwise phenotypic change toward an epithelial monolayer. Molecular analysis during differentiation shows appropriate enrichment in markers of iPSC, definitive endoderm, hepatic specification, hepatic progenitors, and ultimately cholangiocytes. Immunostaining, western blotting, and flow cytometry demonstrate enrichment of multiple functionally relevant biliary proteins. RNA sequencing reveals that the transcriptome moves progressively toward that of human cholangiocytes. iDCs generate intracellular calcium signaling in response to ATP, form intact primary cilia, and self-assemble into duct-like structures in three-dimensional culture. In vivo, the cells engraft within mouse liver, following retrograde intrabiliary infusion. In summary, we have developed a novel approach to generate mature cholangiocytes from iPSCs. In addition to providing a model of biliary differentiation, iDCs represent a platform for in vitro disease modeling, pharmacologic testing, and individualized, cell-based, regenerative therapies for the cholangiopathies.

Original languageEnglish (US)
Pages (from-to)684-696
Number of pages13
JournalLaboratory Investigation
Volume95
Issue number6
DOIs
StatePublished - Jun 28 2015

Fingerprint

Induced Pluripotent Stem Cells
Liver
RNA Sequence Analysis
Endoderm
Calcium Signaling
Cilia
Transcriptome
Liver Diseases
Flow Cytometry
Adenosine Triphosphate
Western Blotting
Cell Line
Proteins

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Cell Biology
  • Molecular Biology

Cite this

Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes. / De Assuncao, Thiago M.; Sun, Yan; Jalan-Sakrikar, Nidhi; Drinane, Mary C.; Huang, Bing Q.; Li, Ying; Davila, Jaime I.; Wang, Ruisi; O'Hara, Steven P.; Lomberk, Gwen A.; Urrutia, Raul A.; Ikeda, Yasuhiro H; Huebert, Robert C.

In: Laboratory Investigation, Vol. 95, No. 6, 28.06.2015, p. 684-696.

Research output: Contribution to journalArticle

De Assuncao, TM, Sun, Y, Jalan-Sakrikar, N, Drinane, MC, Huang, BQ, Li, Y, Davila, JI, Wang, R, O'Hara, SP, Lomberk, GA, Urrutia, RA, Ikeda, YH & Huebert, RC 2015, 'Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes', Laboratory Investigation, vol. 95, no. 6, pp. 684-696. https://doi.org/10.1038/labinvest.2015.51
De Assuncao TM, Sun Y, Jalan-Sakrikar N, Drinane MC, Huang BQ, Li Y et al. Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes. Laboratory Investigation. 2015 Jun 28;95(6):684-696. https://doi.org/10.1038/labinvest.2015.51
De Assuncao, Thiago M. ; Sun, Yan ; Jalan-Sakrikar, Nidhi ; Drinane, Mary C. ; Huang, Bing Q. ; Li, Ying ; Davila, Jaime I. ; Wang, Ruisi ; O'Hara, Steven P. ; Lomberk, Gwen A. ; Urrutia, Raul A. ; Ikeda, Yasuhiro H ; Huebert, Robert C. / Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes. In: Laboratory Investigation. 2015 ; Vol. 95, No. 6. pp. 684-696.
@article{c228d92c5011416eb417a204bbb4ccda,
title = "Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes",
abstract = "Cholangiocytes are the target of a heterogeneous group of liver diseases known as the cholangiopathies. An evolving understanding of the mechanisms driving biliary development provides the theoretical underpinnings for rational development of induced pluripotent stem cell (iPSC)-derived cholangiocytes (iDCs). Therefore, the aims of this study were to develop an approach to generate iDCs and to fully characterize the cells in vitro and in vivo. Human iPSC lines were generated by forced expression of the Yamanaka pluripotency factors. We then pursued a stepwise differentiation strategy toward iDCs, using precise temporal exposure to key biliary morphogens, and we characterized the cells, using a variety of morphologic, molecular, cell biologic, functional, and in vivo approaches. Morphology shows a stepwise phenotypic change toward an epithelial monolayer. Molecular analysis during differentiation shows appropriate enrichment in markers of iPSC, definitive endoderm, hepatic specification, hepatic progenitors, and ultimately cholangiocytes. Immunostaining, western blotting, and flow cytometry demonstrate enrichment of multiple functionally relevant biliary proteins. RNA sequencing reveals that the transcriptome moves progressively toward that of human cholangiocytes. iDCs generate intracellular calcium signaling in response to ATP, form intact primary cilia, and self-assemble into duct-like structures in three-dimensional culture. In vivo, the cells engraft within mouse liver, following retrograde intrabiliary infusion. In summary, we have developed a novel approach to generate mature cholangiocytes from iPSCs. In addition to providing a model of biliary differentiation, iDCs represent a platform for in vitro disease modeling, pharmacologic testing, and individualized, cell-based, regenerative therapies for the cholangiopathies.",
author = "{De Assuncao}, {Thiago M.} and Yan Sun and Nidhi Jalan-Sakrikar and Drinane, {Mary C.} and Huang, {Bing Q.} and Ying Li and Davila, {Jaime I.} and Ruisi Wang and O'Hara, {Steven P.} and Lomberk, {Gwen A.} and Urrutia, {Raul A.} and Ikeda, {Yasuhiro H} and Huebert, {Robert C}",
year = "2015",
month = "6",
day = "28",
doi = "10.1038/labinvest.2015.51",
language = "English (US)",
volume = "95",
pages = "684--696",
journal = "Laboratory Investigation",
issn = "0023-6837",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes

AU - De Assuncao, Thiago M.

AU - Sun, Yan

AU - Jalan-Sakrikar, Nidhi

AU - Drinane, Mary C.

AU - Huang, Bing Q.

AU - Li, Ying

AU - Davila, Jaime I.

AU - Wang, Ruisi

AU - O'Hara, Steven P.

AU - Lomberk, Gwen A.

AU - Urrutia, Raul A.

AU - Ikeda, Yasuhiro H

AU - Huebert, Robert C

PY - 2015/6/28

Y1 - 2015/6/28

N2 - Cholangiocytes are the target of a heterogeneous group of liver diseases known as the cholangiopathies. An evolving understanding of the mechanisms driving biliary development provides the theoretical underpinnings for rational development of induced pluripotent stem cell (iPSC)-derived cholangiocytes (iDCs). Therefore, the aims of this study were to develop an approach to generate iDCs and to fully characterize the cells in vitro and in vivo. Human iPSC lines were generated by forced expression of the Yamanaka pluripotency factors. We then pursued a stepwise differentiation strategy toward iDCs, using precise temporal exposure to key biliary morphogens, and we characterized the cells, using a variety of morphologic, molecular, cell biologic, functional, and in vivo approaches. Morphology shows a stepwise phenotypic change toward an epithelial monolayer. Molecular analysis during differentiation shows appropriate enrichment in markers of iPSC, definitive endoderm, hepatic specification, hepatic progenitors, and ultimately cholangiocytes. Immunostaining, western blotting, and flow cytometry demonstrate enrichment of multiple functionally relevant biliary proteins. RNA sequencing reveals that the transcriptome moves progressively toward that of human cholangiocytes. iDCs generate intracellular calcium signaling in response to ATP, form intact primary cilia, and self-assemble into duct-like structures in three-dimensional culture. In vivo, the cells engraft within mouse liver, following retrograde intrabiliary infusion. In summary, we have developed a novel approach to generate mature cholangiocytes from iPSCs. In addition to providing a model of biliary differentiation, iDCs represent a platform for in vitro disease modeling, pharmacologic testing, and individualized, cell-based, regenerative therapies for the cholangiopathies.

AB - Cholangiocytes are the target of a heterogeneous group of liver diseases known as the cholangiopathies. An evolving understanding of the mechanisms driving biliary development provides the theoretical underpinnings for rational development of induced pluripotent stem cell (iPSC)-derived cholangiocytes (iDCs). Therefore, the aims of this study were to develop an approach to generate iDCs and to fully characterize the cells in vitro and in vivo. Human iPSC lines were generated by forced expression of the Yamanaka pluripotency factors. We then pursued a stepwise differentiation strategy toward iDCs, using precise temporal exposure to key biliary morphogens, and we characterized the cells, using a variety of morphologic, molecular, cell biologic, functional, and in vivo approaches. Morphology shows a stepwise phenotypic change toward an epithelial monolayer. Molecular analysis during differentiation shows appropriate enrichment in markers of iPSC, definitive endoderm, hepatic specification, hepatic progenitors, and ultimately cholangiocytes. Immunostaining, western blotting, and flow cytometry demonstrate enrichment of multiple functionally relevant biliary proteins. RNA sequencing reveals that the transcriptome moves progressively toward that of human cholangiocytes. iDCs generate intracellular calcium signaling in response to ATP, form intact primary cilia, and self-assemble into duct-like structures in three-dimensional culture. In vivo, the cells engraft within mouse liver, following retrograde intrabiliary infusion. In summary, we have developed a novel approach to generate mature cholangiocytes from iPSCs. In addition to providing a model of biliary differentiation, iDCs represent a platform for in vitro disease modeling, pharmacologic testing, and individualized, cell-based, regenerative therapies for the cholangiopathies.

UR - http://www.scopus.com/inward/record.url?scp=84929851353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929851353&partnerID=8YFLogxK

U2 - 10.1038/labinvest.2015.51

DO - 10.1038/labinvest.2015.51

M3 - Article

VL - 95

SP - 684

EP - 696

JO - Laboratory Investigation

JF - Laboratory Investigation

SN - 0023-6837

IS - 6

ER -